Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H S Pall

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Journal of Neurochemistry|April 1, 1988
Synthesis and nuclear magnetic resonance spectroscopic, mass spectroscopic, and plasma amine oxidase inhibitory properties of analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineA R Bhatti, J Burdon, A C Williams, et al.
Neurorehabilitation and Neural Repair|February 22, 2007
Duration of Parkinson disease is associated with an increased propensity for "reinvestment"R S W Masters, H S Pall, K M A MacMahon, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1987
Movement disorder associated with abnormal copper metabolism and decreased blood antioxidantsH S Pall, A C Williams, D R Blake, et al.
Lancet (London, England)|August 1, 1987
Raised cerebrospinal-fluid copper concentration in Parkinson's diseaseH S Pall, A C Williams, D R Blake, et al.
Advances in Neurology|January 1, 1993
N-methylation of pyridines and Parkinson's diseaseA C Williams, H S Pall, G B Steventon, et al.
Neurology|June 30, 2006
ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)N Parkinson, P G Ince, M O Smith, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Journal of Neurochemistry|April 1, 1988
Synthesis and nuclear magnetic resonance spectroscopic, mass spectroscopic, and plasma amine oxidase inhibitory properties of analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineA R Bhatti, J Burdon, A C Williams, et al.
Neurorehabilitation and Neural Repair|February 22, 2007
Duration of Parkinson disease is associated with an increased propensity for "reinvestment"R S W Masters, H S Pall, K M A MacMahon, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1987
Movement disorder associated with abnormal copper metabolism and decreased blood antioxidantsH S Pall, A C Williams, D R Blake, et al.
Lancet (London, England)|August 1, 1987
Raised cerebrospinal-fluid copper concentration in Parkinson's diseaseH S Pall, A C Williams, D R Blake, et al.
Advances in Neurology|January 1, 1993
N-methylation of pyridines and Parkinson's diseaseA C Williams, H S Pall, G B Steventon, et al.
Neurology|June 30, 2006
ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)N Parkinson, P G Ince, M O Smith, et al.
Pageof 3